StockNews.com began coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Get Rating) in a report released on Friday. The firm issued a sell rating on the biotechnology company’s stock. Separately, LADENBURG THALM/SH SH upgraded shares of Ayala Pharmaceuticals from a neutral rating to a buy rating in a report on Tuesday, May 30th. Ayala Pharmaceuticals […]